Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

Journal for Immunotherapy of Cancer
A P FayT K Choueiri

Abstract

Adrenocortical carcinoma (ACC) is a rare tumor in which prognostic factors are still not well established. Programmed Death Ligand-1 (PD-L1) expression in ACC and its association with clinico-pathological features and survival outcomes are unknown. Formalin-fixed paraffin-embedded (FFPE) specimens were obtained from 28 patients with ACC. PD-L1 expression was evaluated by immunohistochemistry (IHC) in both tumor cell membrane and tumor infiltrating mononuclear cells (TIMC). PD-L1 positivity on tumor cells was defined as ≥5% tumor cell membrane staining. TIMC were evaluated by IHC using a CD45 monoclonal antibody. For PD-L1 expression in TIMC, a combined score based on the extent of infiltrates and percentage of positive cells was developed. Any score greater that zero was considered PD-L1 positive. Baseline clinico-pathological characteristics and follow up data were retrospectively collected. Comparisons between PD-L1 expression and clinico-pathological features were evaluated using unpaired t-test and Fisher's exact test. Kaplan-Meier method and log-rank test were used to assess association between PD-L1 expression and 5-year overall survival (OS). Among 28 patients with surgically treated ACC, 3 (10.7%) were considered PD-L1 ...Continue Reading

References

Apr 26, 1990·The New England Journal of Medicine·J P LutonP Blondeau
Jun 1, 1985·Journal of Surgical Oncology·C P KarakousisR Moore
May 23, 1998·World Journal of Surgery·A Khorram-ManeshL E Tisell
Jul 2, 1998·The New England Journal of Medicine·H S WillenbergS R Bornstein
Aug 12, 1998·American Journal of Respiratory and Critical Care Medicine·K J HaleyJ M Drazen
Dec 6, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T S KhanB Eriksson
Dec 1, 2004·Proceedings of the National Academy of Sciences of the United States of America·R Houston ThompsonEugene D Kwon
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuichiro OhigashiYoshiyuki Nakajima
May 9, 2006·World Journal of Surgery·Electron KebebewAlex McMillan
Oct 26, 2006·The Journal of Clinical Endocrinology and Metabolism·Guillaume AssiéEric Baudin
Jan 24, 2007·Clinical Genitourinary Cancer·R Houston Thompson, Eugene D Kwon
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·R Houston ThompsonEugene D Kwon
Feb 16, 2008·Lancet·Alberto MantovaniFrancesco M Marincola
Oct 16, 2008·The Journal of Clinical Endocrinology and Metabolism·Ferdous M BarlaskarGary D Hammer
Jan 2, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giovanni LughezzaniPierre I Karakiewicz
Jul 20, 2010·Immunological Reviews·Loise M FranciscoArlene H Sharpe
Feb 11, 2011·Arthritis Care & Research·Christine HsiehMarcus R Clark
Oct 18, 2011·The Annals of Thoracic Surgery·Jan op den WinkelBruno Allolio
May 4, 2012·The New England Journal of Medicine·Martin FassnachtUNKNOWN FIRM-ACT Study Group
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jul 28, 2012·The Journal of Clinical Endocrinology and Metabolism·Matthias KroissMartin Fassnacht
Aug 8, 2012·Clinical Lung Cancer·Jennifer M BolandMarie Christine Aubry
Mar 21, 2013·British Journal of Cancer·S A Quezada, K S Peggs
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jan 10, 2014·Cancer Medicine·David F McDermott, Michael B Atkins
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Ciara O'SullivanTito Fojo
Jun 25, 2014·Critical Reviews in Oncology/hematology·André P FayToni K Choueiri
Aug 8, 2014·The Cancer Journal·Lauren C HarshmanF Stephen Hodi
Sep 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T K ChoueiriS Signoretti

❮ Previous
Next ❯

Citations

Aug 12, 2015·Endocrine-related Cancer·T M A KerkhofsH R Haak
Nov 28, 2015·Surgical Pathology Clinics·Aymen Elfiky
Jun 19, 2015·Cell Death & Disease·Y JiangB Zhu
Mar 10, 2017·Current Opinion in Endocrinology, Diabetes, and Obesity·Jeena Varghese, Mouhammed Amir Habra
Nov 8, 2018·Endocrine Connections·Deborah CosentiniAlfredo Berruti
Oct 24, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nitya RajDiane L Reidy-Lagunes
Oct 28, 2019·Oncoimmunology·Emilien BillonFrançois Bertucci
Sep 20, 2019·Journal for Immunotherapy of Cancer·Mouhammed Amir HabraAung Naing
Sep 13, 2019·The Journal of Clinical Endocrinology and Metabolism·Julie LangKatja Kiseljak-Vassiliades
Apr 28, 2016·Current Opinion in Endocrinology, Diabetes, and Obesity·Bhavana Konda, Lawrence S Kirschner
Mar 20, 2020·Journal for Immunotherapy of Cancer·Aung NaingMouhammed Amir Habra
Apr 23, 2016·Oncotarget·Ricardo CostaFrancis J Giles
Apr 25, 2017·Journal of Hematology & Oncology·Kathan MehtaRahul A Parikh
Jul 16, 2020·Journal of the Endocrine Society·Kevin C MillerKeith C Bible
Feb 25, 2019·Current Oncology Reports·Sina Jasim, Mouhammed Amir Habra
Oct 19, 2019·Arkhiv patologii·L S SelivanovaG A Melnichenko
Nov 9, 2018·International Journal of Molecular Sciences·Shravanti MacherlaMahvish Muzaffar
May 7, 2019·Journal of Oncology·Chiara FiorentiniSandra Sigala
Jul 20, 2019·Medical Oncology·Ali Mohamed AlshabiChanabasayya Vastrad
Jan 23, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joan M RomeroSteven Gallinger
Jan 28, 2021·Biomedicines·Izabela KarwackaKrzysztof Sworczak
Apr 27, 2021·Expert Opinion on Emerging Drugs·Vineeth SukrithanBhavana Konda
May 1, 2021·Cancers·Natalia GeorgantzoglouStamatios Theocharis
Jul 17, 2021·Journal of Inflammation Research·Wenlu ZouYan Hao

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
surgical
biopsies

Software Mentioned

SAS

Related Concepts

Related Feeds

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.